2023 ESC Guidelines for the management of acute coronary syndromes
Рекомендации ESC 2023 года по ведению пациентов с острыми коронарными синдромами
2023-08-25
SCID: 54.1/3knkzkkg
Discuss with AI
2023 ESC GuidelinesESC Guidelines 2023acute coronary syndromesmanagement of acute coronary syndromes
Figures from the paper
Abstract (AI)
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication.The ESC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Key Findings
1
2023 ESC Guidelines provide updated recommendations for management of acute coronary syndromes.
2
The document serves as a clinical guideline from the European Society of Cardiology for acute coronary syndrome care in 2023.
3
The guidelines are intended as a standardized reference for diagnosis and treatment decisions in acute coronary syndromes.
Research Object
Management of acute coronary syndromes (clinical guidelines)
Research Subject
Recommended diagnostic, therapeutic, and care pathways for patients with acute coronary syndromes including risk stratification, reperfusion, antithrombotic therapy, and secondary prevention
Publication Details
Publication Date
2023-08-25
Journal
Publisher
ISSN
Cited by
5269
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai12
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk2019
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017
Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest2002
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2020
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2019
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction2019
2015 ESC Guidelines for the diagnosis and management of pericardial diseases2015
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology2020
Cited by3
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2024
Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the National Health and Nutrition Examination Survey 1999–20182024
Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial2025